Document:

Exhibit 10.2

 

 

EXECUTIVE
EMPLOYMENT AGREEMENT

 

This
Agreement is made effective as of the 1st day of July, 2016.

 

BETWEEN:

 

DELMAR
PHARMACEUTICALS INC. and DELMAR PHARMACEUTICALS (BC) LTD.

Suite
720 – 999 West Broadway

Vancouver, B.C., V5Z 1K5

 

(together the
“Company”)

 

AND:

 

SCOTT
PRAILL

Suite 720 – 999 West Broadway

Vancouver,
B.C., V5Z 1K5

(the “Employee”)

 

WITNESSES THAT WHEREAS:

 

A.          The
Company is involved in the development and commercialization of new cancer therapies; and

 

B.           The
Company wishes to employ the Employee and the Employee has agreed to accept employment on the terms and conditions hereinafter
set forth.

 

THEREFORE
in consideration of the following representations and covenants, the sufficiency of which is acknowledged by each party, the
parties agree on the following terms:

 

1.            Employment

 

1.1          The
Company hereby agrees to employ the Employee in the position of Chief Financial Officer of the Company and the Employee hereby
agrees to such employment on the terms and conditions herein.

 

1.2          The
Employee shall report to the Chief Executive Officer of the Company, and shall be responsible for the day-to-day financial operations
of the Company and its affiliates, and shall perform the duties assigned to him from time to time by the Chief Executive Officer
or the Board of Directors of the Company (the ‘Board”) that are consistent with his position.

 

    

     

    

 

1.3          Throughout
the term of this Agreement, the Employee shall:

 

		(a)	diligently,
                                         honestly and faithfully serve the Company and shall use his best efforts to promote and
                                         advance the interests and goodwill of the Company;

 

		(b)	conduct
                                         himself at all times in a manner which is not prejudicial to the Company’s interests;

 

		(c)	devote
                                         his full time and attention to the business and affairs of the Company as is necessary
                                         to fulfil his obligations hereunder;

 

		(d)	refrain
                                         from engaging in any activity which shall in any manner, directly or indirectly, compete
                                         with the trade or business of the Company;

 

		(e)	comply
                                         and conduct himself in accordance with all employee policies and procedures established
                                         by the Company from time to time; and

 

		(f)	undertake
                                         and/or delegate all senior administrative responsibilities pertaining to the day-to-day
                                         operations of the Company, in accordance with the policies established by the Board.

 

1.4         
The Employee may sit on the board of directors of other companies or organizations with the written consent of the Board.

 

1.5          The
Employee acknowledges and agrees that he is a fiduciary of the Company. Without in any way limiting the scope of the Employee’s
fiduciary obligations to the Company, the Employee agrees that, at all times during the term of this Agreement, the Employee shall
not engage in competition with the Company, its affiliates or subsidiaries, aid others in any unfair competition with the Company,
its affiliates or subsidiaries, in any way breach the confidence that the Company has placed in the Employee, misappropriate any
proprietary or confidential information of the Company, or misappropriate any corporate opportunities of the Company.

 

1.6          The
Employee acknowledges and agrees that he will be required to work regularly at the Company’s offices in Vancouver, British
Columbia and travel as is reasonably necessary to fulfill the requirements of his position.

 

2.            Term
of Employment

 

2.1          The
Employee’s employment hereunder shall be for an indefinite term, and shall continue until terminated in accordance with
the terms of section 4 or 5 of this Agreement.

 

3.            Remuneration
and Benefits

 

3.1          Remuneration

 

3.1.1       During
this Agreement, the Company shall pay to the Employee a salary of $200,000 per annum (“Base Salary”). The Base Salary
shall be paid in accordance with the regular payroll practices of the Company. The Company will consider salary adjustments on
an annual basis but any future salary increases shall be at the sole discretion of the Board.

 

    	 	2

     

    

 

3.1.2       The
Company shall have the right to deduct and withhold from the Employee’s compensation any amounts required to be deducted
and remitted under applicable provincial and federal laws of Canada.

 

3.2          Bonus

 

3.2.1       The
Employee shall be entitled to participate in any incentive and/or bonus plan established by the Company for senior executives.
For the 2016/2017 fiscal year, the Employee shall be eligible for a target bonus of up to 25% of the Base Salary based on milestones
to be set by the Board in consultation with the Employee. Future bonus milestones shall be set by the Board in consultation with
the Employee.

 

3.3          Long
Term Incentive Plan

 

The
Employee shall also be entitled to participate in any long term incentive programs made available to senior executives, including
the Company’s stock option plan. For the 2016/2017 year the Company shall provide long term incentive compensation valued
using Black Scholes at $100,000. The form of these incentives shall be at the discretion of the Board. Any further grants of options
or other long term incentives shall be at the sole discretion of the Board.

 

3.4          Benefits

 

3.4.1       The
Employee shall be eligible to participate in all Canadian employee benefit plans, as applicable, if and when made available to
executive-level employees, subject to the terms and conditions of any applicable benefit plan.

 

3.4.2       The
Company shall pay the Employee a monthly supplemental benefits allowance in the amount of $800 to purchase critical illness and
disability insurance.

 

3.5          Reimbursement
of Business Expenses

 

The
Company shall reimburse the Employee for all reasonable expenses actually and properly incurred by the Employee in the performance
of his duties for the Company. The Employee shall furnish to the Company such statements, vouchers and other particulars of expenses
as the Company may reasonably require.

 

3.6          Vacation

 

The
Employee shall be credited with a vacation bank of thirty (30) paid vacation days upon execution of this Agreement. From the date
of execution of this Agreement, the Employee shall accrue thirty (30) days’ paid vacation in each calendar year during the
term of this Agreement; however, the Employee’s vacation bank shall be capped at thirty (30) paid vacation days. The timing
of vacations shall be in accordance with the Company’s policies and practices for senior management personnel and with the
Company’s needs and shall be approved by either the Chair (if the Employee is not the Chair) or the lead independent director.
Any accrued but unused vacation will only be paid out to the Employee on termination of employment.

 

    	 	3

     

    

 

4.            Termination

 

4.1          The
Company may terminate the Employee’s employment under this Agreement at any time for cause. If this Agreement and the Employee’s
employment are terminated for cause, no notice, salary, compensation, benefits, allowances or pay in lieu of notice shall be paid
or payable to the Employee after or as a result of such termination other than the Base Salary to the effective date of such termination.

 

4.2          The
Company may terminate the Employee’s employment under this Agreement without cause at any time by providing the Employee
with the following:

 

		(a)	as
                                         a lump sum payment at the time of termination:

 

		(i)	if
                                         not theretofore paid, the amount of the Employee's accrued and unpaid Base Salary and
                                         vacation pay for the period up to and including the effective date of termination;

 

		(ii)	all
                                         employee benefits received by the Employee from the Company shall continue for period
                                         of one (1) year from the effective date of termination, subject to the terms of the applicable
                                         benefit plans, and in the event that any such benefits cannot be continued by the Company,
                                         the Company shall reimburse the Employee for one (1) year of comparable replacement coverage
                                         obtained by the Employee; and

 

		(iii)	an
                                         amount equal to twelve (12) months of Base Salary at that time plus one additional month
                                         of Base Salary for each completed year of service commencing from the date of this Agreement
                                         to a maximum of eighteen (18) months’ Base Salary.

 

		(b)	all
                                         unvested options and any other LTIP compensation shall vest upon the effective date of
                                         that termination and any unexercised portion of such options or LTIP will be exercisable
                                         by the Employee for up to one year from the date of termination.

 

4.3          The
Employee may terminate his obligations under this Agreement without cause by giving three (3) months’ written notice to
the Board (the “Resignation Period”). On the giving of such notice by the Employee, or at any time thereafter, the
Company shall have the right to immediately terminate the Employee’s employment, by providing to the Employee a lump sum
payment equal to the Base Salary payable during the balance of the Resignation Period. Any employee benefits received by the Employee
from the Company shall continue to the end of the Resignation Period, subject to the terms of the applicable benefit plan. In
the event that there are any benefits that the Company cannot continue for the duration of the Resignation Period, the Company
will reimburse the Employee comparable replacement coverage obtained by the Employee during the Resignation Period.

 

4.4          The
Employee acknowledges and agrees that unless otherwise expressly agreed in writing between the Employee and the Company, the Employee
shall not be entitled, by reason of his employment with the Company or by reason of any termination of such employment, however
so arising, to any remuneration, compensation or other benefits other than as expressly provided for in this Agreement.

 

    	 	4

     

    

 

5.            Change
of Control

 

5.1          For
the purposes of this Agreement "Change in Control" means:

 

		(a)	there
                                         is direct or indirect acquisition by a person or group of persons acting jointly or in
                                         concert of voting securities of the Company (as defined in the Securities Act,
                                         R.S.B.C. 1996, c. 418 as the same may be amended from time to time and any successor
                                         legislation thereto) that when taken together with any other voting securities owned
                                         directly or indirectly by such person or group of persons at the time of the acquisition,
                                         constitute 50% or more of the outstanding voting securities of the Company; or

 

		(b)	a
                                         majority of the then-incumbent Board of Directors’ nominees for election to the
                                         Board of Directors of the Company are not elected at any annual or special meeting of
                                         shareholders of the Company; or

 

		(c)	there
                                         is a sale, transfer or other disposition of all or substantially all of the assets of
                                         the Company;

 

		(d)	there
                                         is a liquidation, dissolution or winding-up of the Company; or

 

		(e)	there
                                         is a merger, amalgamation, consolidation or reorganization into or with another body
                                         corporate or other legal person and, as a result of such business combination, more than
                                         50% of the voting shares of such body corporate or legal person immediately after such
                                         transaction are beneficially held in the aggregate by a person or body corporate (or
                                         persons or bodies corporate acting jointly or in concert) and such person or body corporate
                                         (or persons or bodies corporate acting jointly or in concert) beneficially held less
                                         than 40% of the voting shares of the Company immediately prior to such transaction.

 

5.2           If
the Employee’s employment is terminated by the Company without cause or for Good Reason during the twelve (12) month period
following Change of Control, the Employee shall be entitled to be paid and to receive from the Company the amounts and benefits
provided in Section 5.4 below.

 

5.3           For
the Purposes of this Agreement, “Good Reason” means any one or more of the following events, occurring following a
Change of Control and without the Employee’s written consent:

 

		(a)	the
                                         Employee is placed in a position of lesser stature than his current position, is assigned
                                         duties that, would result in a material change in the nature or scope of powers, authority,
                                         functions or duties inherent in such a position immediately prior to the Change of Control;

 

		(b)	a
                                         decrease in the Employee’s Base Salary or a decrease in the Employee’s incentive
                                         bonus, benefits, vacation or other compensation;

 

		(c)	a
                                         requirement that the Employee relocate to a location greater than forty (40) kilometers
                                         from the Employee’s primary work location immediately prior to a Change of Control;
                                         or

 

		(d)	any
                                         action or event that would constitute constructive dismissal of the Employee at common
                                         law.

 

    	 	5

     

    

 

5.4          Compensation
Upon Termination

 

In
the event the Employee’s employment is terminated pursuant to Section 5.2, the Company shall pay the following amounts and
provide the following benefits, all less applicable statutory deductions, to the Employee within ten (10) days of the effective
date of termination:

 

		(a)	if
                                         not already paid, the Employee’s Base Salary and accrued vacation, if any, to the
                                         effective date of termination;

 

		(b)	an
                                         amount equivalent to two (2) times the Base Salary;

 

		(c)	all
                                         employee benefits received be the Employee from the Company shall continue for period
                                         of one (1) year from the effective date of termination, subject to the terms of the applicable
                                         benefit plans, and in the event that any such benefits cannot be continued by the Company,
                                         the Company shall reimburse the Employee for one (1) year of comparable replacement coverage
                                         obtained by the Employee; and

 

		(d)	all
                                         unvested options and any other LTIP compensation shall vest upon the effective date of
                                         termination and any unexercised portion of such options or LTIP will be exercisable by
                                         the Employee for up to one (1) year from the effective date of termination.

 

6.           Confidentiality
and Non-Competition

 

6.1          Except
as required by law or in the normal and proper course of the Employee’s duties hereunder, the Employee will not use for
the Employee’s own account or disclose to anyone else, during or after the term of this Agreement, any confidential or proprietary
information or material relating to the operations or business of the Company and its affiliates which the Employee obtains from
the Company, any affiliates or their officers, employees, agents, suppliers or customers or otherwise by virtue of the Employee’s
employment by the Company or its affiliates. Confidential or proprietary information or material includes, without limitation,
the following types of information or material, both existing and contemplated, regarding the Company or its affiliates except
to the extent otherwise in the public domain: corporate information, including plans, strategies, tactics, policies, resolutions,
and any litigation or negotiations; financial information, including cost and performance data, debt arrangements, equity structure,
investors and holdings; operational and scientific information, including trade secrets; technical information, technical drawings
and designs; research results and personnel information, including personnel lists, resumes, personnel data, organizational structure
and performance evaluations (collectively, the “Confidential Information”).

 

6.2          The
Employee agrees that all documents (including, without limitation, software and information in machine-readable form) of any nature
pertaining to activities of the Company and its affiliates, including without limitation, Confidential Information, in the Employee’s
possession now or at any time during the term of this agreement, are and shall be the property of the Company and its affiliates,
and that all such documents and all copies of them shall be surrendered to the Company whenever requested by the Company.

 

    	 	6

     

    

 

6.3          The
Employee shall not, for a period of twelve (12) months following the termination of the Employee’s employment for any reason,
without the prior written consent of the Board, either individually or in partnership or jointly or in conjunction with any other
person, as principal, agent, consultant, lender, contractor, employer, employee, investor or shareholder, or in any other manner,
directly or indirectly, advise, manage, carry on, establish, acquire control of, be engaged in, invest in or lend money to, guarantee
the obligations of, or permit the Employee’s name or any part thereof to be used or employed by any person that operates,
is engaged in or has an interest in a business in Canada or the Unites States that is substantially similar or competes with the
business of the Company. For the purposes of this Agreement, the business of the Company is the development and commercialization
of chemotherapy drugs used to treat glioblastoma multiforme (“GBM”). Nothing in this section 6.3 shall prevent the
Employee from acquiring or holding not more than 5% of the shares of a company whose shares are listed on a public stock exchange.

 

6.4          The
Employee shall not, for a period of twelve (12) months following the termination of the Employee’s employment for any reason,
without the prior written consent of the Board, for his account or jointly with another, either directly or indirectly, for or
on behalf of himself or any individual, partnership, corporation or other legal entity, as principal, agent, employee or otherwise,
solicit, influence, entice or induce, or attempt to solicit, influence, entice or induce:

 

		(a)	any
                                         person who is employed by the Company or any affiliated company to leave such employment;
                                         or

 

		(b)	any
                                         person, firm or corporation whatsoever, who or which has at any time in the last two
                                         (2) years of the Employee's employment with the Company or any predecessor of the Company,
                                         been a customer of the Company, any affiliated company, or of any of their respective
                                         predecessors, provided that this subsection shall not prohibit the Employee from soliciting
                                         business from any such customer if the business is in no way similar to the business
                                         carried on by the Company, an affiliated company, any of their respective predecessors,
                                         subsidiaries or associates to cease its relationship with the Company or any affiliated
                                         company.

 

6.5          The
Employee acknowledges that, in connection with the Employee’s employment by the Company, the Employee will receive or will
become eligible to receive substantial benefits and compensation. The Employee acknowledges that the Employee’s employment
by the Company and all compensation and benefits and potential compensation and benefits to the Employee from such employment
will be conferred by the Company upon the Employee only because and on condition of the Employee’s willingness to commit
the Employee’s best efforts and loyalty to the Company, including protecting the Company’s right to have its Confidential
Information protected from non-disclosure by the Employee and abiding by the confidentiality, and other provisions herein. The
Employee understands the Employee’s duties and obligations as set forth in this section and agrees that such duties and
obligations would not unduly restrict or curtail the Employee’s legitimate efforts to earn a livelihood following any termination
of the Employee’s employment with the Company. The Employee agrees that the restrictions contained in this section 6 are
reasonable and valid. The Employee further acknowledges and agrees that the Company shall be entitled to any appropriate legal,
equitable, or other remedy, including injunctive relief, in respect of any failure or continuing failure of the Employee to comply
with the provisions of this section 5.

 

    	 	7

     

    

 

7.            Representations
and Warranties

 

7.1          The
Employee represents and warrants to the Company that the execution and performance of this Agreement will not result in or constitute
a default, breach, or violation, or an event that, with notice or lapse of time or both, would be a default, breach, or violation,
of any understanding, agreement or commitment, written or oral, express or implied, to which the Employee is a party or by which
the Employee or the Employee’s property is bound.

 

8.            General

 

8.1          Employment
Standards

 

In
the event that the minimum standards in the Employment Standards Act, R.S.B.C. 1996, c. 113, as it exists from time to
time, are more favourable to the Employee in any respect, including but not limited to the provisions herein in respect to notice
of termination or vacation entitlement than provided for herein, the provisions of the Employment Standards Act shall apply.

 

8.2          Waiver

 

No
consent or waiver, express or implied, by any party to this Agreement or any breach or default by any other party in the performance
of its obligations under this Agreement or of any of the terms, covenants or conditions of this Agreement shall be deemed or construed
to be a consent or waiver of any subsequent or continuing breach or default in such party’s performance or in the terms,
covenants or conditions of this Agreement. The failure of any party to this Agreement to assert any claim in a timely fashion
for any of its rights or remedies under this Agreement shall not be construed as a waiver of any such claim and shall not serve
to modify, alter or restrict any such party’s right to assert such claim at any time thereafter.

 

The
provisions of section 6 shall survive the termination of this Agreement.

 

8.3           Notices

 

Any
notice relating to this Agreement or required or permitted to be given in accordance with this Agreement shall be in writing and
shall be personally delivered or mailed by registered mail, postage prepaid if to the Company to the address of the Company set
out on the first page of this Agreement and if to the Employee to the home address of the Employee on the Company’s records.
Any notice shall be deemed to have been received if delivered, when delivered, and if mailed, on the fifth day (excluding Saturdays,
Sundays and holidays) after the mailing thereof. If normal mail service is interrupted the sender shall deliver such notice in
order to ensure prompt receipt thereof. A party may change its address for service by notice in writing to the other party.

 

8.4          Applicable
Law

 

This
Agreement shall be governed by and construed in accordance with the laws of the province of British Columbia and the federal laws
of Canada applicable therein, which shall be deemed to be the proper law hereof. The parties hereto hereby submit to the non-exclusive
jurisdiction of the courts of British Columbia.

 

    	 	8

     

    

 

8.5          Severability

 

If
any provision of this Agreement for any reason is declared invalid, such declaration shall not affect the validity of any remaining
portion of the Agreement, which remaining portion shall remain in full force and effect as if this Agreement had been executed
with the invalid portion thereof eliminated and it is hereby declared the intention of the parties that they would have executed
the remaining portions of this Agreement without including therein any such part, parts or portion which may, for any reason,
be hereafter declared invalid.

 

8.6          Entire
Agreement

 

This
Agreement constitutes the entire Agreement between the parties hereto and there are no representations or warranties, express
or implied, statutory or otherwise other than as set forth in this Agreement and there are no Agreements collateral hereto other
than as are expressly set forth or referred to herein. This Agreement supersedes any prior agreements, written or oral in respect
of the Employee’s employment with or engagement by the Company, including the Consulting Services Agreement between the
parties dated January 2015. This Agreement cannot be amended or supplemented except by a written agreement executed by all parties
hereto.

 

8.7          Counterpart

 

This
Agreement may be executed in counterparts and such counterparts together shall constitute one and the same instrument and notwithstanding
the date of execution shall be deemed to bear the date as set out on the first page of this Agreement.

 

8.8          Currency

 

Except
as expressly indicated otherwise, all sums of money referred to in this Agreement are expressed and shall be payable in United
States dollars.

 

8.9          Independent
Legal Advice

 

The
Employee acknowledges that this Agreement has been prepared by the Company’s solicitors and acknowledges that the Employee
has had sufficient time to review this Agreement thoroughly, that he has read and understood the terms of this Agreement and that
the Employee has been given the opportunity to obtain independent legal advice concerning the interpretation and effect of this
Agreement prior to its execution.

 

    	 	9

     

    

 

IN
WITNESS WHEREOF the parties have executed this Agreement as of the 9th day of February 2017.

 

	 	DELMAR
    PHARMACEUTICALS INC.
	 	 
	 	Per:	/s/ Lynda Cranston
	 	 	Authorized
    Signatory
	 	 	 
	 	DELMAR
    PHARMACEUTICALS (BC) LTD.
	 	 
	 	Per:	/s/ Jeffrey Bacha
	 	 	Authorized
    Signatory

 

	SIGNED,
    SEALED AND DELIVERED in the 

    presence of:	 	)

                                                                                )
	 
	 	 	)	 
		 	)	 
	Witness	 	)	
		 	)	 
	 	 	)	/s/
    Scott Praill
	Name	 	)	SCOTT
PRAILL
	 	 	)	 
		 	)	 
	Address	 	)	 
	 	 	 	 
	 	 	)	 
		 	)	 
	 	 	)	 
	Occupation	 		 

 

 

 

10Exhibit
10.3

 

AMENDMENT
TO CONSULTING AGREEMENT

 

This
Amendment to the consultant agreement (this “Amendment”), dated as of February 9, 2017, is entered into
by Del Mar Pharmaceuticals (BC) Ltd. (the “Company”), a wholly owned subsidiary of DelMar Pharmaceuticals, Inc., and
Dennis Brown (the “Consultant”).

 

WITNESSETH:

 

WHEREAS,
on January 1, 2015 the Company and the Consultant entered into a consulting agreement (the “Agreement”);

 

WHEREAS,
the Company and the Consultant desire to amend the Agreement as more particularly set forth below;

 

NOW,
THEREFORE, in consideration of the covenants and mutual promises contained herein and other good and valuable consideration, the
receipt and legal sufficiency of which are hereby acknowledged and intending to be legally bound hereby, the parties agree as
follows:

 

1.           The
Term (section 5.1) is hereby amended to mean December 31, 2017.

 

2.           The
Effective Date of this Amendment shall be January 1, 2017.

 

3.           Section
2.4 of the Agreement shall be amended as follows:

 

In
recognition of the Consultant’s services to the Company during the term of this Agreement, the Company shall pay the Consultant
$200,000 (the “Fee”) payable in equal installments of $16,666.67 on the first day of each month during the Term.

 

At
the sole discretion of the Company’s Board of Directors, the Consultant may be considered for a bonus or may participate
in the Company’s long term incentive plans. All payments, issuance, or grants under either the bonus or long term incentive
compensation plan are at the sole discretion of the Company’s Board of Directors.

 

4.           Except
as modified herein, the terms of the Agreement have and shall remain in full force and effect.

 

5.           This
Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and
shall be binding upon all parties, their successors and assigns, and all of which taken together shall constitute one and the
same Amendment. A signature delivered by facsimile shall constitute an original.

 

[Signature
Page Follows]

 

    	 		 

     

    

 

[SIGNATURE
PAGE TO THE AMENDMENT TO THE AGREEMENT]

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date set forth above.

 

	DEL
    MAR PHARMACEUTICALS (BC) LTD.	 
	 	 	 
	By:
    	 /s/ Jeffrey
    A. Bacha	 
	Name:
    	Jeffrey
    A. Bacha	 
	Title:
    	CEO,
    Director	 
	 	 	 
	CONSULTANT:  	 
	 	 	 
	 	/s/
    Dennis
    Brown       	 
	Name:	Dennis
    Brown

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]